Q15561 (TEAD4_HUMAN) Homo sapiens (Human)
Transcriptional enhancer factor TEF-3 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
20 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| TEAD4 (216-434);E263A+Y429F COMPLEXED WITH YAP PEPTIDE (60- 100);S94A AND MYRISTOATE (COVALENTLY BO… |
Heteromer P46937; | 1×MYR; 1×PO4; | ||||
| Assess | ||||||
| X-ray structure of TEAD4(Y429H) mutant) complexed with YAP (wildtype): Molecular and structural cha… |
Heteromer P46937; | 1×MYR; 2×PO4; | ||||
| Assess | ||||||
| Crystal structure of TEAD4 in complex with YAP peptide |
Heteromer P46937; | 2×MYR; | ||||
| Assess | ||||||
| X-ray structure of TEAD4(E263A+Y429F mutant) complexed with YAP(wildtype): The role of residual fle… |
Heteromer P46937; | 1×MYR; 4×PO4; | ||||
| Assess | ||||||
| TEAD4 (216-434) COMPLEXED WITH YAP PEPTIDE (60-100);S94A AND MYRISTOATE (COVALENTLY BOUND) AT 1.70A… |
Heteromer P46937; | 1×MYR; | ||||
| Assess | ||||||
| X-ray structure of TEAD4 (wildtype) complexed with YAP (wildtype): The role of residual flexibility… |
Heteromer P46937; | 1×MYR; 1×GOL; | ||||
| Assess | ||||||
| TEAD4 COMPLEXED WITH YAP PEPTIDE AND MYRISTATE (COVALENTLY BOUND) |
Heteromer P46937; | 1×GOL; 1×MYR; | ||||
| Assess | ||||||
| TEAD4 (216-434);E263A COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) A… |
Heteromer P46937; | 1×MYR; | ||||
| Assess | ||||||
| TEAD4 (216-434);E263A COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 1.97… |
Heteromer P46937; | 1×MYR; | ||||
| Assess | ||||||
| TEAD4(216-434) complexed with optimized peptide 9 and myristoate (covalently bound) at 2.01A resolu… |
Heteromer | 2×MYR; 4×PO4; | ||||
| Assess | ||||||
| TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.05… |
Heteromer P46937; | 1×MYR; | ||||
| Assess | ||||||
| TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) A… |
Heteromer P46937; | 1×MYR; | ||||
| Assess | ||||||
| Crystal structure of TEAD4 in complex with peptide 1 |
Heteromer | 4×GOL; 2×MYR; | ||||
| Assess | ||||||
| TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.28… |
Heteromer P46937; | 1×MYR; | ||||
| Assess | ||||||
| TEAD4 bound to a FAM181A peptide |
Heteromer Q8N9Y4; | 3×SO4; | ||||
| Assess | ||||||
| TEAD4 (216-434) COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.1A (P412… |
Heteromer P46937; | 1×GOL; 1×MYR; | ||||
| Assess | ||||||
| TEAD4 bound to a FAM181B peptide |
Heteromer A6NEQ2; | |||||
| Assess | ||||||
| TEAD4-HOXB13 complex bound to DNA |
Heteromer Q92826; | |||||
| Assess | ||||||
| Crystal structure of TEAD4 in complex with YTP-13 | homo-2-mer | 2×U3F; 2×U3O; 1×PO4; | ||||
| Assess | ||||||
| Crystal Structure of Transcription Factor TEAD4 in Complex with M-CAT DNA | monomer | 1×GOL; 1×PO4; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6gek.2.A | monomer | 0.76 | 1×MYR; | 99.54 | ||
| Assess | ||||||
| 4z8e.1.A | monomer | 0.58 | 93.94 | |||
| Assess | ||||||
| 5gzb.1.A | monomer | 0.55 | 100.00 | |||
| Assess | ||||||
4 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6hik.1.A | monomer | 0.79 | 1×MYR; | 99.54 | |
| Assess | ||||||
| Isoform 3 | 6gek.2.A | monomer | 0.76 | 1×MYR; | 99.54 | |
| Assess | ||||||
| Isoform 3 | 4z8e.1.A | monomer | 0.58 | 93.94 | ||
| Assess | ||||||
| Isoform 3 | 5gzb.1.A | monomer | 0.50 | 100.00 | ||
| Assess | ||||||